These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 19138963)

  • 1. Focusing downstream in lung cancer prevention: 15-hydroxyprostaglandin dehydrogenase.
    Dubinett SM; Mao JT; Hazra S
    Cancer Prev Res (Phila); 2008 Sep; 1(4):223-5. PubMed ID: 19138963
    [No Abstract]   [Full Text] [Related]  

  • 2. NAD+-linked 15-hydroxyprostaglandin dehydrogenase (15-PGDH) behaves as a tumor suppressor in lung cancer.
    Ding Y; Tong M; Liu S; Moscow JA; Tai HH
    Carcinogenesis; 2005 Jan; 26(1):65-72. PubMed ID: 15358636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 15-hydroxyprostaglandin dehydrogenase is a tumor suppressor of human breast cancer.
    Wolf I; O'Kelly J; Rubinek T; Tong M; Nguyen A; Lin BT; Tai HH; Karlan BY; Koeffler HP
    Cancer Res; 2006 Aug; 66(15):7818-23. PubMed ID: 16885386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NAD+-dependent 15-hydroxyprostaglandin dehydrogenase regulates levels of bioactive lipids in non-small cell lung cancer.
    Hughes D; Otani T; Yang P; Newman RA; Yantiss RK; Altorki NK; Port JL; Yan M; Markowitz SD; Mazumdar M; Tai HH; Subbaramaiah K; Dannenberg AJ
    Cancer Prev Res (Phila); 2008 Sep; 1(4):241-9. PubMed ID: 19138967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of cyclooxygenase-1 and cyclooxygenase-2 in bronchial epithelium and nonsmall cell lung carcinoma.
    Hastürk S; Kemp B; Kalapurakal SK; Kurie JM; Hong WK; Lee JS
    Cancer; 2002 Feb; 94(4):1023-31. PubMed ID: 11920472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reciprocal regulation of cyclooxygenase-2 and 15-hydroxyprostaglandin dehydrogenase expression in A549 human lung adenocarcinoma cells.
    Tong M; Ding Y; Tai HH
    Carcinogenesis; 2006 Nov; 27(11):2170-9. PubMed ID: 16632868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Death receptor regulation and celecoxib-induced apoptosis in human lung cancer cells.
    Liu X; Yue P; Zhou Z; Khuri FR; Sun SY
    J Natl Cancer Inst; 2004 Dec; 96(23):1769-80. PubMed ID: 15572759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 15-Hydroxyprostaglandin dehydrogenase can be induced by dexamethasone and other glucocorticoids at the therapeutic level in A549 human lung adenocarcinoma cells.
    Tong M; Tai HH
    Arch Biochem Biophys; 2005 Mar; 435(1):50-5. PubMed ID: 15680906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 15-Hydroxyprostaglandin dehydrogenase as a novel molecular target for cancer chemoprevention and therapy.
    Na HK; Park JM; Lee HG; Lee HN; Myung SJ; Surh YJ
    Biochem Pharmacol; 2011 Nov; 82(10):1352-60. PubMed ID: 21856294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclooxygenase as a target in lung cancer.
    Brown JR; DuBois RN
    Clin Cancer Res; 2004 Jun; 10(12 Pt 2):4266s-4269s. PubMed ID: 15217972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormal interleukin 10Ralpha expression contributes to the maintenance of elevated cyclooxygenase-2 in non-small cell lung cancer cells.
    Heuze-Vourc'h N; Zhu L; Krysan K; Batra RK; Sharma S; Dubinett SM
    Cancer Res; 2003 Feb; 63(4):766-70. PubMed ID: 12591723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-small cell lung cancer cyclooxygenase-2-dependent regulation of cytokine balance in lymphocytes and macrophages: up-regulation of interleukin 10 and down-regulation of interleukin 12 production.
    Huang M; Stolina M; Sharma S; Mao JT; Zhu L; Miller PW; Wollman J; Herschman H; Dubinett SM
    Cancer Res; 1998 Mar; 58(6):1208-16. PubMed ID: 9515807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel transmembrane GTPase of non-small cell lung cancer identified by mRNA differential display.
    Chung JG; Yeh KT; Wu SL; Hsu NY; Chen GW; Yeh YW; Ho HC
    Cancer Res; 2001 Dec; 61(24):8873-9. PubMed ID: 11751411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thymidine phosphorylase levels and dihydropyrimidine dehydrogenase levels in non-small cell lung cancer tissues.
    Chujo M; Miura T; Kawano Y; Miyawaki M; Imakiire T; Hayashita Y; Kawahara K
    Oncol Rep; 2006 Oct; 16(4):777-80. PubMed ID: 16969493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The expression of DNA methyltransferases and methyl-CpG-binding proteins is not associated with the methylation status of p14(ARF), p16(INK4a) and RASSF1A in human lung cancer cell lines.
    Sato M; Horio Y; Sekido Y; Minna JD; Shimokata K; Hasegawa Y
    Oncogene; 2002 Jul; 21(31):4822-9. PubMed ID: 12101420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 15-Hydroxyprostaglandin dehydrogenase is a target of hepatocyte nuclear factor 3beta and a tumor suppressor in lung cancer.
    Huang G; Eisenberg R; Yan M; Monti S; Lawrence E; Fu P; Walbroehl J; Löwenberg E; Golub T; Merchan J; Tenen DG; Markowitz SD; Halmos B
    Cancer Res; 2008 Jul; 68(13):5040-8. PubMed ID: 18593902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Matrix metalloproteinase-13 expression is associated with bone marrow microinvolvement and prognosis in non-small cell lung cancer.
    Hsu CP; Shen GH; Ko JL
    Lung Cancer; 2006 Jun; 52(3):349-57. PubMed ID: 16569461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Chemoprevention in non-small cell bronchial cancers].
    van Zandwijk N
    Rev Pneumol Clin; 2002 Nov; 58(5 Pt 2):3S51-3. PubMed ID: 12538937
    [No Abstract]   [Full Text] [Related]  

  • 19. Topoisomerase IIalpha gene expression is regulated by the p53 tumor suppressor gene in nonsmall cell lung carcinoma patients.
    Liu D; Huang CL; Kameyama K; Hayashi E; Yamauchi A; Sumitomo S; Yokomise H
    Cancer; 2002 Apr; 94(8):2239-47. PubMed ID: 12001123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [2000 Standards, Options and Recommendations for prognostic value of oncogenes and tumor suppressor genes in non small cell lung cancer].
    Bréchot JM; Molina T; Theobald S; Depierre A; Lagrange JL; Astoul P; Baldeyrou P; Bardet E; Bazelly B; Breton JL; Douillard JY; Grivaux M; Jacoulet P; Khalil A; Lemarié E; Martinet Y; Massard G; Milleron B; Moro-Sibilot D; Paesmans M; Pujol JL; Quoix AE; Ranfaing E; Rivière A; Sancho-Garnier H; Souquet PJ; Spaeth D; Stcebner-Delbarre A;
    Bull Cancer; 2002 Oct; 89(10):857-67. PubMed ID: 12441277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.